Medvita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 16,443,006 | 37,410,651 | 44,784,060 | 61,978,446 | 80,715,942 | 62,453,014 | 47,127,844 | 19,000,318 |
| Profit before tax | 756,457 | 2,433,467 | 5,314,878 | 5,567,110 | -648,758 | -118,042 | 324,146 | -15,434 |
| Net profit | 600,640 | 2,060,779 | 4,496,481 | 4,699,690 | -618,764 | -47,140 | 305,418 | -9,059 |
| Equity | 2,606,762 | 4,567,541 | 9,086,764 | 13,386,454 | 12,367,690 | 12,320,550 | 12,625,968 | 12,616,909 |
| Liabilities | 1,553,593 | 1,993,227 | 2,282,538 | 2,963,304 | 6,075,697 | 3,031,000 | 574,415 | 412,154 |
| Non-current assets | 976,211 | 904,406 | 1,555,780 | 2,677,625 | 3,847,080 | 4,181,479 | 6,209,694 | 6,173,733 |
| Current assets | 3,221,074 | 5,983,882 | 10,214,190 | 13,958,981 | 14,242,537 | 10,320,157 | 5,888,466 | 6,496,323 |
| Total assets | 4,197,285 | 6,888,288 | 11,769,970 | 16,636,606 | 18,089,617 | 14,501,636 | 12,098,160 | 12,670,056 |
|
Taxes paid
|
||||||||
| Social insurance contributions | - | - | - | - | - | 355,996 | 352,546 | 282,819 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +72.7% | +127.5% | +19.7% | +38.4% | +30.2% | -22.6% | -24.5% | -59.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.3% | 29.9% | 38.2% | 28.2% | -3.4% | -0.3% | 2.5% | -0.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.0% | 45.1% | 49.5% | 35.1% | -5.0% | -0.4% | 2.4% | -0.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.7% | 5.5% | 10.0% | 7.6% | -0.8% | -0.1% | 0.6% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.6% | 6.5% | 11.9% | 9.0% | -0.8% | -0.2% | 0.7% | -0.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.4 | 0.3 | 0.2 | 0.5 | 0.2 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,038,508 | 1,282,649 | 1,170,825 | 1,211,304 | 1,377,798 | 954,695 | 702,527 | 417,589 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medvita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-09-27 | 2024-09-29 | 27.00 |
| 2024-01-16 | 2024-01-17 | 30694.29 |
Medvita - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medvita, UAB is a Private Limited Liability Company (code 160423187) engaged in the wholesale of wood, construction materials and sanitary equipment. In 2025, the latest financial year, revenue declined to €19.00M from €47.13M in 2024 and €62.45M in 2023, showing a sharp two-year contraction in turnover. Net result for 2025 was a loss of €9.1K, after a profit of €305.4K in 2024 and a loss of €47.1K in 2023, indicating results around break-even despite much lower sales. The 2025 profit margin was effectively flat at -0.0%, while ROE and ROA were both -0.1%. Balance sheet structure remained strong, with equity of €12.62M, liabilities of €412.2K and total assets of €12.67M. The equity ratio was 99.6%, debt-to-equity 0.03, and asset turnover 1.50x. Revenue per employee was €422.2K, while profit per employee was -€201, reflecting weak profitability in the latest year despite a solid capital base.